Vericel (VCEL) Other Non-Current Assets (2019 - 2026)
Vericel (VCEL) reported Other Non-Current Assets of $288000.0 for Q1 2026, down 42.51% on a YoY basis from $501000.0 in Q1 2025, and down 15.54% sequentially from $341000.0 in Q4 2025.
Vericel (VCEL) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Vericel (VCEL) has 8 years of Other Non-Current Assets data on file, last reported at $288000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 42.51% year-over-year to $288000.0; the trailing twelve-month figure through Mar 2026 stood at $288000.0 (down 42.51% YoY), and the FY2025 full-year result was $341000.0, down 38.67% from the prior year.
- Other Non-Current Assets fell to $288000.0 in Q1 2026, from $341000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q3 2022 to a low of $288000.0 in Q1 2026.
- A 5-year average of $715941.2 and a median of $610000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets jumped 543.13% in 2022 and tumbled 46.58% in 2024, its largest moves.
- Tracing VCEL's Other Non-Current Assets over 5 years: stood at $1.3 million in 2022, then sank by 40.83% to $771000.0 in 2023, then retreated by 27.89% to $556000.0 in 2024, then tumbled by 38.67% to $341000.0 in 2025, then retreated by 15.54% to $288000.0 in 2026.
- Business Quant data shows VCEL's Other Non-Current Assets at $288000.0 in Q1 2026, $341000.0 in Q4 2025, and $395000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 288,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288,000.00 |
| Dec 31, 2025 | 341,000.00 |
| Sep 30, 2025 | 395,000.00 |
| Jun 30, 2025 | 447,000.00 |
| Mar 31, 2025 | 501,000.00 |
| Dec 31, 2024 | 556,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 664,000.00 |
| Mar 31, 2024 | 717,000.00 |
| Dec 31, 2023 | 771,000.00 |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.25 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 317,000.00 |
| Mar 31, 2022 | 317,000.00 |
| Dec 31, 2021 | 211,000.00 |
| Sep 30, 2021 | 211,000.00 |
| Jun 30, 2021 | 211,000.00 |